Review article · 2023
Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs
Current Pharmaceutical Design, 29(29), 2297–2312 · Published 1 August 2023 · DOI 10.2174/1381612829666230911105922
In brief
“Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs” is a 2023 review article by Mohamed T. Elsebay and 4 co-authors, published in Current Pharmaceutical Design. OpenAlex counts 15 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 15
- Most cited in
- 2025 (7)
- Field-weighted impact
- 0.29
- References
- 143
- Authors
- 5
Abstract
The poor water solubility of numerous novel drug candidates presents significant challenges, particularly in terms of oral administration. This limitation can result in various undesirable clinical implications, such as inter-patient variability, poor bioavailability, difficulties in achieving a safe therapeutic index, increased costs, and potential risks of toxicity or inefficacy. Biopharmaceutics Classification System (BCS) class II… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Elsebay, M. T., Eissa, N. G., Balata, G. F., Kamal, M. A., & El-Nahas, H. M. (2023). Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs. Current Pharmaceutical Design, 29(29), 2297–2312. https://doi.org/10.2174/1381612829666230911105922
MLA 9
Elsebay, Mohamed T., et al. “Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.” Current Pharmaceutical Design, vol. 29, no. 29, 2023, pp. 2297–2312. https://doi.org/10.2174/1381612829666230911105922.
Chicago
Elsebay, Mohamed T., Noura G. Eissa, Gehan Fathy Balata, Mohammad Amjad Kamal, and Hanan M. El-Nahas. 2023. “Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.” Current Pharmaceutical Design 29 (29): 2297–2312. https://doi.org/10.2174/1381612829666230911105922.
Harvard
Elsebay, M. T. et al. (2023) ‘Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs’, Current Pharmaceutical Design, 29(29), pp. 2297–2312. doi:10.2174/1381612829666230911105922.
IEEE
M. T. Elsebay, N. G. Eissa, G. F. Balata, M. A. Kamal, and H. M. El-Nahas, “Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs,” Current Pharmaceutical Design, vol. 29, no. 29, pp. 2297–2312, 2023, doi: 10.2174/1381612829666230911105922.
BibTeX
@article{elsebay2023nanosuspension,
title = {{Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs}},
author = {Elsebay, Mohamed T. and Eissa, Noura G. and Balata, Gehan Fathy and Kamal, Mohammad Amjad and El-Nahas, Hanan M.},
journal = {Current Pharmaceutical Design},
year = {2023},
volume = {29},
number = {29},
pages = {2297--2312},
doi = {10.2174/1381612829666230911105922},
url = {https://doi.org/10.2174/1381612829666230911105922}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 1 | |
| 2025 | 7 | |
| 2026 | 7 |
Its field-weighted citation impact is 0.29: it has been cited 0.29 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- nanoparticle suspensions
- poorly water-soluble drugs
- drug solubility enhancement
- bioavailability
- oral drug delivery
- parenteral drug delivery
- Biopharmaceutics Classification System class II
- stabilizers
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Elsebay, M. T., Eissa, N. G., Balata, G. F., Kamal, M. A., & El-Nahas, H. M. (2023). Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs. Current Pharmaceutical Design, 29(29), 2297–2312. https://doi.org/10.2174/1381612829666230911105922
How many times has this paper been cited?
15 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Mohamed T. Elsebay, Noura G. Eissa, Gehan Fathy Balata, Mohammad Amjad Kamal, Hanan M. El-Nahas.
What is the DOI of this paper?
10.2174/1381612829666230911105922. The permanent link is https://doi.org/10.2174/1381612829666230911105922.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.